Continuous Glucose Monitoring Devices Market | Top Trends, Growth & Future Outlook 2025 | DataM Intelligence

The Global Continuous Glucose Monitoring Devices Market is estimated to reach at a Significant CAGR during the forecast period 2024-2031.

AUSTIN, TX, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- Market Overview:

Continuous Glucose Monitoring Devices Market have revolutionized diabetes management by providing real-time glucose readings, enabling better glycemic control. These devices are increasingly favored over traditional monitoring methods due to their ability to offer continuous data, reducing the need for frequent finger-prick tests. The market encompasses various components, including sensors, transmitters, receivers/displays, and integration with insulin pumps.

To Download Sample Report: https://www.datamintelligence.com/download-sample/continuous-glucose-monitoring-devices-market

Market Drivers and Opportunities:

Rising Diabetes Prevalence: The global increase in diabetes cases, particularly Type 2 diabetes, has escalated the demand for effective glucose monitoring solutions. The World Health Organization reports that over 422 million people worldwide have diabetes, with numbers expected to rise significantly by 2045.

Technological Advancements: Innovations such as non-invasive sensors, extended device wearability, and smartphone integration have enhanced user convenience and monitoring accuracy. For instance, the development of wearable optical sensors for non-invasive sweat glucose detection represents a significant leap forward.

Expanding Applications: Beyond diabetes management, CGMs are gaining traction among health-conscious individuals and athletes for metabolic health monitoring, indicating a broader market potential.

Market Segmentation:

By Components:
Sensors
Transmitters
Receivers/Displays
Insulin Pumps Integration
Others.

By Application:
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes.

By End User:
Hospitals & Clinics
Homecare Settings
Diagnostic Centers
Others.

By Region:
North America
Europe
South America
Asia Pacific
Middle East
Africa.

Geographical Market Share:

North America dominates the continuous glucose monitoring (CGM) market, owing to a large number of diabetes cases, well-developed healthcare systems, and a history of early adoption of new technology. In 2024, the United States alone contributed USD 3.7 billion in CGM market value, with forecasts indicating that it may rise to USD 8.4 billion by 2033.

Asia-Pacific: Expected to witness the highest growth rate, driven by the large diabetic population in countries like India and China, increasing healthcare awareness, and government initiatives to improve diabetes care.

Europe: Maintains a significant market share due to supportive healthcare policies and a growing elderly population requiring continuous glucose monitoring.

Key Market Players:

The CGM market is characterized by the presence of several key players focusing on product innovation and strategic collaborations:

Abbott Laboratories
Medtronic Plc
Medtrum Technologies Inc
Biolinq Incorporated
Dexcom, Inc.
Menarini Diagnostics S.r.l.
Ypsomed AG
Senseonics Holdings, Inc
Nemaura
LifeScan IP Holdings, LLC.

Recent Developments:

United States
March 2024: The FDA approved Dexcom's over-the-counter CGM tailored for Type 2 diabetes patients, enhancing accessibility and affordability.

In February 2024, the FDA designated Senseonics' Eversense device as integrated CGM (iCGM), demonstrating advances in long-term glucose monitoring systems.

Japan
January 2025: Samsung announced plans to develop a non-invasive CGM feature for its wearable devices, signaling technological advancements in the Japanese market.

July 2021: Terumo Corporation launched the Dexcom G6 CGM System in Japan, supporting diabetes control with real-time glucose readings and predictive alerts.

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Conclusion:

The Continuous Glucose Monitoring Devices market is on an upward trajectory, fueled by the global diabetes epidemic, technological innovations, and expanding applications beyond traditional diabetes care. With significant investments in research and development, strategic collaborations, and a focus on user-friendly, non-invasive solutions, the CGM market is poised for sustained growth, offering improved quality of life for individuals worldwide.

Related Reports:

Brain Monitoring Devices Market

Cardiac Monitoring Devices Market

Sai Kiran
DataM Intelligence 4Market Research
+1 877-441-4866
Sai.k@datamintelligence.com
Visit us on social media:
LinkedIn
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.